Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

23.1K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
23.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ATTNSOM: learning cross-isoform attention for cytochrome P450 site-of-metabolism prediction.

Bioinformatics (Oxford, England)·2026
Same author

irAE.AI: AI-powered exploration of real-world immune-related adverse events.

JAMIA open·2026
Same author

Targeting of MEK and Autophagy in Pancreatic Adenocarcinoma and Analysis of Treatment Sensitivity in Preclinical and Clinical Models: MEKiAUTO.

JCO precision oncology·2026
Same author

Clinico-genomic nomograms for estimation of survival risk in metastatic castrate-resistant prostate cancer.

JNCI cancer spectrum·2026
Same author

Associations Between Two-Year Immune-Related Adverse Events and Psychological Distress and Subsequent Survival Outcomes Among ICI-Treated Survivors Diagnosed With Advanced Cancers in the US.

Psycho-oncology·2026
Same author

Impact of baseline medications on real-world overall survival in immune checkpoint inhibitor-treated patients with cancer in the RADIOHEAD cohort.

Med (New York, N.Y.)·2026

Related Experiment Video

Updated: Apr 12, 2026

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.5K

DSigDB: drug signatures database for gene set analysis.

Minjae Yoo1, Jimin Shin1, Jihye Kim1

  • 1Department of Medicine, Translational Bioinformatics and Cancer Systems Biology Laboratory, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA and Department of Computer Science and Engineering, Korea University, Seoul 136-713, South Korea.

Bioinformatics (Oxford, England)
|May 21, 2015
PubMed
Summary

We created the Drug Signatures Database (DSigDB), a resource linking compounds to target genes for gene set enrichment analysis (GSEA). This database aids in drug repurposing and translational research by connecting gene expression data with drug information.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K

Related Experiment Videos

Last Updated: Apr 12, 2026

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research
09:35

A Protocol for Using Gene Set Enrichment Analysis to Identify the Appropriate Animal Model for Translational Research

Published on: August 16, 2017

18.5K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

8.1K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.7K

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Pharmacogenomics

Background:

  • Gene set enrichment analysis (GSEA) is crucial for interpreting high-throughput gene expression data.
  • Identifying relationships between compounds and their target genes is essential for drug discovery.
  • Existing resources may lack comprehensive links between drugs and gene expression profiles.

Purpose of the Study:

  • To develop a comprehensive database, Drug Signatures Database (DSigDB), that maps compounds to their target genes.
  • To facilitate the use of this resource in gene set enrichment analysis (GSEA).
  • To support drug repurposing and translational research by integrating compound-gene relationships.

Main Methods:

  • Compiled a database of gene sets linking compounds to target genes.
  • Developed an online platform for searching, viewing, and downloading data.
  • Ensured seamless integration with GSEA software.

Main Results:

  • DSigDB contains 22,527 gene sets, 17,389 unique compounds, and 19,531 genes.
  • An accessible online resource is now available for researchers.
  • The database enables linking gene expression data with specific drugs and compounds.

Conclusions:

  • DSigDB provides a valuable resource for GSEA, drug repurposing, and translational research.
  • The integrated platform simplifies the exploration of compound-gene interactions.
  • This resource has the potential to accelerate the discovery of new therapeutic applications for existing compounds.